A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma

BACKGROUND: To evaluate the clinical utility of LIM Domain Only 2 (LMO2) negative and CD38 positive in diagnosis of Burkitt lymphoma (BL). METHODS: LMO2 and CD38 expression determined by immunohistochemistry in 75 BL, 12 High-grade B-cell lymphoma, NOS (HGBL,NOS) and 3 Burkitt-like lymphomas with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yifei, Bian, Tingting, Zhang, Yanlin, Zheng, Yuanyuan, Zhang, Jianguo, Zhou, Xiaoge, Xie, Jianlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727582/
https://www.ncbi.nlm.nih.gov/pubmed/31484540
http://dx.doi.org/10.1186/s13000-019-0876-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727582/
https://www.ncbi.nlm.nih.gov/pubmed/31484540
http://dx.doi.org/10.1186/s13000-019-0876-3

Ejemplares similares